Elicera Therapeutics AB

NEW
OSTO:ELIC (Sweden)   Ordinary Shares
kr 2.84 +0.14 (+5.19%) Sep 9
At Loss
P/B:
3.38
Market Cap:
kr 189.53M ($ 19.77M)
Enterprise V:
kr 131.40M ($ 13.70M)
Volume:
476.41K
Avg Vol (2M):
386.66K
Trade In:
Volume:
476.41K
At Loss
Avg Vol (2M):
386.66K

Elicera Therapeutics AB (OSTO:ELIC) Dividend

Elicera Therapeutics AB (OSTO:ELIC) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -34.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: OSTO:ELIC Dividend

Does Elicera Therapeutics AB (OSTO:ELIC) pay a dividend?

Elicera Therapeutics AB (OSTO:ELIC) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Elicera Therapeutics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Elicera Therapeutics AB has returned capital to shareholders via buybacks at a rate of -34.9% over the past 3 years.

What are dividend-paying alternatives to Elicera Therapeutics AB?

For dividend-paying alternatives in Elicera Therapeutics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.